Literature DB >> 19525020

Oxidized low-density lipoprotein, angiotensin II and increased waist cirumference are associated with valve inflammation in prehypertensive patients with aortic stenosis.

Nancy Côté1, Philippe Pibarot, Andrée Pépin, Dominique Fournier, Audrey Audet, Benoît Arsenault, Christian Couture, Paul Poirier, Jean-Pierre Després, Patrick Mathieu.   

Abstract

INTRODUCTION: The progression of aortic stenosis (AS) has been shown to be faster in patients with the metabolic syndrome. We sought to determine the relationships between blood pressure, inflammation, oxidative stress and valvular inflammation in a population of normotensive and prehypertensive patients with AS.
METHODS: In this study, 36 male patients (age: 61.5±2 years) with AS undergoing an aortic valve replacement were investigated. Plasma levels of adiponectin, oxidized-LDL (ox-LDL), angiotensinogen (AGN) and angiotensin I-II (Ang I-II) were measured. On explanted aortic valves, immunohistochemistry studies and quantitative PCR (q-PCR) analyses were performed to document the expression of inflammatory cytokines.
RESULTS: Systolic blood pressure (SBP) was positively correlated with plasma level of ox-LDL (r=0.4; p=0.02), AGN (r=0.41; p=0.01), and white blood cells count (r=0.33; p=0.04), whereas it was inversely related to plasma level of adiponectin (r=-.35; p=0.04). After adjustment for covariates, plasma level of ox-LDL (p=0.01) remained significantly associated with SBP (p=0.01). Within the aortic valve, expression of TNF-α was significantly associated with plasma levels of ox-LDL (r=0.58; p=0.03), Ang II (r=0.69; p=0.013), and waist circumference (r=0.60; p=0.02), whereas valvular expression of IL-6 was associated with plasma level of Ang II (r=0.51; p=0.03). In explanted AS valves, ox-LDL was documented near calcified areas and colocalized with Ang II, IL-6, and TNF-α.
CONCLUSION: Conditions associated with a higher oxidative stress and activation of the renin angiotensin system, such as encountered in viscerally obese and prehypertensive patients, contribute to higher valvular inflammation in AS.
Copyright © 2009 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19525020     DOI: 10.1016/j.ijcard.2009.05.054

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  12 in total

Review 1.  The Pathogenesis and treatment of the valvulopathy of aortic stenosis: Beyond the SEAS.

Authors:  Sammy Elmariah; Emile R Mohler
Journal:  Curr Cardiol Rep       Date:  2010-03       Impact factor: 2.931

2.  Systolic hypertension and progression of aortic valve calcification in patients with aortic stenosis: results from the PROGRESSA study.

Authors:  Lionel Tastet; Romain Capoulade; Marie-Annick Clavel; Éric Larose; Mylène Shen; Abdellaziz Dahou; Marie Arsenault; Patrick Mathieu; Élisabeth Bédard; Jean G Dumesnil; Alexe Tremblay; Yohan Bossé; Jean-Pierre Després; Philippe Pibarot
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2016-02-18       Impact factor: 6.875

3.  Calcific aortic valve disease: from molecular and cellular mechanisms to medical therapy.

Authors:  Simon Kraler; Mark C Blaser; Elena Aikawa; Giovanni G Camici; Thomas F Lüscher
Journal:  Eur Heart J       Date:  2022-02-12       Impact factor: 29.983

Review 4.  Mechanisms and Drug Therapies of Bioprosthetic Heart Valve Calcification.

Authors:  Shuyu Wen; Ying Zhou; Wai Yen Yim; Shijie Wang; Li Xu; Jiawei Shi; Weihua Qiao; Nianguo Dong
Journal:  Front Pharmacol       Date:  2022-06-03       Impact factor: 5.988

Review 5.  Calcific aortic stenosis.

Authors:  Brian R Lindman; Marie-Annick Clavel; Patrick Mathieu; Bernard Iung; Patrizio Lancellotti; Catherine M Otto; Philippe Pibarot
Journal:  Nat Rev Dis Primers       Date:  2016-03-03       Impact factor: 52.329

6.  Biglycan induces the expression of osteogenic factors in human aortic valve interstitial cells via Toll-like receptor-2.

Authors:  Rui Song; Qingchun Zeng; Lihua Ao; Jessica A Yu; Joseph C Cleveland; Ke-Seng Zhao; David A Fullerton; Xianzhong Meng
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-09-13       Impact factor: 8.311

7.  Calcific Aortic Valve Disease: Molecular Mechanisms and Therapeutic Approaches.

Authors:  Daniel Alejandro Lerman; Sai Prasad; Nasri Alotti
Journal:  Eur Cardiol       Date:  2015

8.  Gene Profiling of Aortic Valve Interstitial Cells under Elevated Pressure Conditions: Modulation of Inflammatory Gene Networks.

Authors:  James N Warnock; Bindu Nanduri; Carol A Pregonero Gamez; Juliet Tang; Daniel Koback; William M Muir; Shane C Burgess
Journal:  Int J Inflam       Date:  2011-08-18

Review 9.  Role of oxidative stress in calcific aortic valve disease and its therapeutic implications.

Authors:  Harry Z E Greenberg; Guoan Zhao; Ajay M Shah; Min Zhang
Journal:  Cardiovasc Res       Date:  2022-05-06       Impact factor: 13.081

Review 10.  Innate and Adaptive Immunity in Calcific Aortic Valve Disease.

Authors:  Patrick Mathieu; Rihab Bouchareb; Marie-Chloé Boulanger
Journal:  J Immunol Res       Date:  2015-05-03       Impact factor: 4.818

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.